These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9604516)

  • 1. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation.
    Soloff PH
    Bull Menninger Clin; 1998; 62(2):195-214. PubMed ID: 9604516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacotherapy in personality disorders].
    Wedekind D; Bandelow B; Rüther E
    Fortschr Neurol Psychiatr; 2005 May; 73(5):259-67. PubMed ID: 15880304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacotherapy in personality disorders: methodological issues and results].
    Pelissolo A; Lepine JP
    Encephale; 1999; 25(5):496-507. PubMed ID: 10598315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychopharmacologic treatment of personality disorders].
    Quante A; Röpke S; Merkl A; Anghelescu I; Lammers CH
    Fortschr Neurol Psychiatr; 2008 Mar; 76(3):139-48. PubMed ID: 18240112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of personality disorders: conceptual framework and clinical strategies.
    Gitlin MJ
    J Clin Psychopharmacol; 1993 Oct; 13(5):343-53. PubMed ID: 8227492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for personality disorders.
    Hori A
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):13-9. PubMed ID: 9682928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: II. Implications for neurobiology, genetics and psychopharmacological treatment.
    Lara DR; Akiskal HS
    J Affect Disord; 2006 Aug; 94(1-3):89-103. PubMed ID: 16712943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological treatment of borderline personality disorders. Several options for symptom reduction but nothing for the disorder per se].
    Rydén G; Vinnars B
    Lakartidningen; 2002 Dec; 99(50):5088-94. PubMed ID: 12572301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy of patients with emotionally unstable personality].
    Nissen T
    Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2135-41. PubMed ID: 11006733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based pharmacotherapy for personality disorders.
    Ripoll LH; Triebwasser J; Siever LJ
    Int J Neuropsychopharmacol; 2011 Oct; 14(9):1257-88. PubMed ID: 21320390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacology of borderline personality disorder.
    Soloff PH
    Psychiatr Clin North Am; 2000 Mar; 23(1):169-92, ix. PubMed ID: 10729938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why patients with severe personality disorders are overmedicated.
    Paris J
    J Clin Psychiatry; 2015 Apr; 76(4):e521. PubMed ID: 25919846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic pain and the measurement of personality: do states influence traits?
    Fishbain DA; Cole B; Cutler RB; Lewis J; Rosomoff HL; Rosomoff RS
    Pain Med; 2006; 7(6):509-29. PubMed ID: 17112364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
    Van den Eynde F; Senturk V; Naudts K; Vogels C; Bernagie K; Thas O; van Heeringen C; Audenaert K
    J Clin Psychopharmacol; 2008 Apr; 28(2):147-55. PubMed ID: 18344724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment for borderline personality disorder.
    Berger PA
    Bull Menninger Clin; 1987 May; 51(3):277-84. PubMed ID: 3580662
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials of treatment for personality disorders.
    Paris J
    Psychiatr Clin North Am; 2008 Sep; 31(3):517-26, viii. PubMed ID: 18638650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of dialectic and behavioral therapy (DBT) and duloxetin in kleptomania].
    Rudel A; Hubert C; Juckel G; Edel MA
    Psychiatr Prax; 2009 Sep; 36(6):293-6. PubMed ID: 18924062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of borderline personality disorder: multiple dimensions, multiple symptoms, but one category.
    Paris J
    J Pers Disord; 2007 Oct; 21(5):457-73. PubMed ID: 17953501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and effectiveness of psychopharmacology in emotionally unstable and borderline personality disorder.
    Silk KR
    J Clin Psychiatry; 2015 Apr; 76(4):e524-5. PubMed ID: 25919848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.